Publications by authors named "S A Hudu"

Metabolic syndrome (MetS) is a widespread global epidemic that affects individuals across all age groups and presents a significant public health challenge. Comprising various cardio-metabolic risk factors, MetS contributes to morbidity and, when inadequately addressed, can lead to mortality. Current therapeutic approaches involve lifestyle changes and the prolonged use of pharmacological agents targeting the individual components of MetS, posing challenges related to cost, compliance with medications, and cumulative side effects.

View Article and Find Full Text PDF

Hepatitis B virus (HBV) infection remains a significant global health concern worldwide, contributing to high rates of mortality and morbidity, including chronic hepatitis B, cirrhosis, and hepatocellular carcinoma (HCC). Universal vaccination programs have significantly reduced the rate of HBV transmission; however, a subset of individuals fail to develop a protective immune response following vaccination and are termed nonresponders. A comprehensive search strategy using the PubMed, Google Scholar, and Web of Science databases was employed to search for relevant studies using keywords including "hepatitis B vaccine", "vaccine nonresponse", "immunogenicity", "immune response to the hepatitis B vaccine", and "associated risk factors".

View Article and Find Full Text PDF

Background: The advent of the hepatitis B vaccine has achieved tremendous success in eradicating and reducing the burden of hepatitis B infection, which is the main culprit for hepatocellular carcinoma-one of the most fatal malignancies globally. Response to the vaccine is achieved in about 90-95% of healthy individuals and up to only 50% in immunocompromised patients. This review aimed to provide an overview of hepatitis B vaccine non-response, the mechanisms involved, B cell amnesia, and strategies to overcome it.

View Article and Find Full Text PDF

A major worldwide health concern, chronic hepatitis B necessitates precise prognostic and diagnostic indicators for clinical guidance. This article highlights the clinical importance and current issues of the major markers used in both the detection and prognosis of chronic hepatitis B. An important indicator of an ongoing and persistent infection is the hepatitis B surface antigen.

View Article and Find Full Text PDF
Article Synopsis
  • - Rett syndrome (RTT) is a rare neurodevelopmental disorder affecting girls, with no effective treatments approved by the USFDA until March 2023, when Trofinetide was finally authorized as the first medication for RTT.
  • - Trofinetide, originally discovered in 2000 by Neuren Pharmaceuticals, is based on a neuroprotective peptide and aims to enhance neuronal structure and function, although its exact mechanism is still unclear.
  • - The approval of Trofinetide marks a significant advancement in RTT treatment, opening doors for further research and clinical trials on related disorders like Fragile X syndrome and autism spectrum disorder.
View Article and Find Full Text PDF